Evoke Pharma, Inc.

Historical 13F Holders

Symbol
EVOK
CUSIP
30049G104
All holders as of
Q1 2022
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q1 23 2.00 M $987 k
2021 Q4 29 2.05 M $1.13 M
2021 Q3 25 4.20 M $5.46 M
2021 Q2 26 4.50 M $6.17 M
2021 Q1 30 4.28 M $7.83 M
2020 Q4 38 2.69 M $6.94 M
2020 Q3 32 1.86 M $8.74 M
2020 Q2 21 1.40 M $4.96 M
2020 Q1 20 1.46 M $1.70 M
2019 Q4 18 1.66 M $2.68 M
2019 Q3 19 1.48 M $1.28 M
2019 Q2 22 1.35 M $842 k
2019 Q1 24 1.81 M $2.69 M
2018 Q4 21 3.21 M $7.97 M
2018 Q3 24 3.23 M $9.64 M
2018 Q2 21 3.17 M $7.92 M
2018 Q1 21 2.49 M $5.17 M
2017 Q4 27 2.85 M $6.45 M
2017 Q3 21 2.10 M $7.02 M
2017 Q2 21 1.98 M $5.07 M
2017 Q1 24 1.81 M $5.61 M
2016 Q4 15 588 k $1.19 M
2016 Q3 13 633 k $1.43 M
2016 Q2 14 446 k $3.06 M
2016 Q1 12 386 k $1.97 M
2015 Q4 14 418 k $1.38 M
2015 Q3 9 511 k $1.49 M
2015 Q2 12 460 k $2.40 M
2015 Q1 12 472 k $3.31 M
2014 Q4 11 404 k $2.41 M
2014 Q3 11 405 k $2.23 M
2014 Q2 10 409 k $3.29 M
2014 Q1 10 412 k $3.45 M